Artificial Intelligence (AI) in Genomics Market By Offering (Solutions, Services); By Technology (Machine Learning, Computer Vision, Others); By Type (Plant Genomics, Animal Genomics, Others); By Function (Genome Sequencing, Gene Editing, Predictive Testing of Genes, Others); By Organization Size (Small and Medium Enterprises, Large Enterprises); By End-Use (Structural Genomics, Functional Genomics); By End-Users (Pharmaceutical Companies, Research Institutions and Life Sciences, Healthcare Providers, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Genomics, a term that was first coined by Thomas Roderick in 1986, refers to the study of the function and structure of a living organism's entire genome. The complete set of genetic information present in an organism is called a genome. Genome is stored in the complex molecules of Deoxyribonucleic acid (DNA), which is called as chromosomes. Genomics is a computer-aided study, and has gained immense attention in the past couple of decades. It primarily deals with the mapping and sequencing of the genes present in the chromosome. Studies show that genomics is more accurate as compared to other methods such as recombination mapping and deletion mapping. The use of genomics is seen in the solving of complex issues related to genetics, and has become an inevitable aspect of both plant and animal breeding, and genetics. Artificial intelligence technology is being increasingly used in the field of genomics, as it has the ability to break down complex scenarios involving millions of combinations, and coming up with the most efficient solution. Computer vision techniques are being used for the capture of high resolution images, especially in the field of plant genomics. The rise in investment in artificial intelligence technology in the field of genomics, which is powered by both private and public entities, coupled with the rise in demand for genetic decoding for gene editing and sequencing, is expected to lead to the growth of the global artificial intelligence (AI) in genomics market in the coming years.
The COVID-19 pandemic has impacted the lives of numerous individuals around the globe. The pandemic has forced government bodies to implement lockdown and social distancing norms to curb the spread of the Coronavirus. However, healthcare and life sciences industry has gained significantly as a result of the pandemic. Companies are increasingly providing solutions that helps in studying human genomics at a microscopic level, and artificial intelligence solutions are being increased used for this purpose. Using genomics, pharmaceutical companies can also come up with tailored therapeutics for patients. Healthcare facilities, on the other hand, can utilize the concept of genomics for analyzing the genetic composition of individuals, and come up with a suitable diagnostic, as well as therapeutic model, especially with the advancement in machine learning technology. Furthermore, disease identification and prevention is being increasingly focussed by public healthcare bodies. Researchers are largely focussing on the use of artificial intelligence techniques to gain more insights about the COVID-19 genome sequences. Sequential pattern mining (SPM) technique, for instance, is applied on a corpus of COVID-19 genome sequence which can be understood by a computer for analyzing patterns. Hence, the pandemic situation has accelerated the adoption of artificial intelligence in genomics, especially for understanding the genetic composition of patients, as well as the COVID-19 virus. Therefore, the pandemic is expected to have a positive impact on the global artificial intelligence (AI) in genomics market in the coming years.
In terms of revenue, artificial intelligence (AI) in genomics market was valued at US$ 458.21 Mn in 2020 growing at a CAGR of 5.67% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Artificial Intelligence (AI) in Genomics Market Revenue & Forecast, (US$ Million), 2015 – 2029
Function Outlook:
Based on the functions, the global artificial intelligence (AI) in genomics market is segmented into genome sequencing, gene editing and predictive gene testing, amongst others. Gene editing, also referred to as genome editing, is a set of technologies that allow scientists to make changes in an organism's DNA. Materials can be added, altered, or removed from a particular DNA to give rise to new genetic features. One of the most recent developments in the field of gene editing is the advent of CRISPR-Cas9 technology, and it is said to be cheaper, accurate and efficient as compared to other gene editing techniques. Genetic defects and diseases are expected to rectify in the coming years as a result of the advancement in gene editing using CRISPR-Cas9. Moreover, the use of AI is expected to make CRISPR technology even more accurate, and safer. The researchers at the Wellcome Sanger Institute, for instance, have developed an algorithm based on machine learning to enhance the efficiency of CRISPR Cas9 gene editing by predicting the errors in advance. The program, which is called FORECasT (favored outcomes of repair events at Cas9 targets), can predict the outcome of gene repairing using CRISPR Cas9, regardless of the operations being insertions or deletions. The researchers predict that diseases which arise as a result of the expansion of short tandem repeats, especially Huntington’s, can be treated using this technology. Gene editing accounted for the highest market share in the global artificial intelligence (AI) in genomics market in 2020.
Region Outlook:
Based on geography, North America accounted for the highest share in the global artificial intelligence (AI) in genomics market. The higher focus on research and development in countries like the U.S. and Canada, coupled with the presence of prominent end-users, especially in the pharmaceutical sector, in North America is a major reason for the higher share of North America in the global artificial intelligence (AI) in genomics market. Furthermore, public bodies are also pouring heavy amounts for genomics research, and artificial intelligence is being seen as a technology that can elevate genomics, especially in predictive testing of genes. U.S. has been at the forefront of precision medicine, and were the first to decipher human genome towards the beginning of 2000. Both the U.S. and Canada is seeing a rise in start-ups that are providing AI-based solutions in genomics. DEEP GENOMICS, for instance, is a Canadian company that is involved in the programming of RNA therapies for any gene or genetic condition with the help of AI. DEEP GENOMIC's AI-powered RNA workbench helps in the untangling of complexities in the RNA, and provides an algorithm that can predict the best possible outcome from thousands of possible results, which is highly cumbersome for humans. However, the APAC region is expected to show the highest growth during the forecast years in the global artificial intelligence (AI) in genomics market, powered by the contribution of countries like India, China, Japan and Singapore. In 2016, the Government of China invested around US$ 9 billion, with a 15 year plan that aims to project the country to be the forefront in the application of artificial intelligence technology in decompressing the complexities in genetics. The country is working closely with companies, mainly based in the U.S., for accessing a patient's genetic data for the creation of machine learning algorithms that can determine the best possible therapeutic and diagnostic method based on their genetic composition. Machine learning models for cancer treatment using genomics is expected to emerge as the next gold rush in the field of healthcare. Guangdong based iCarbonX, for instance, is using machine learning models to facilitate research in life sciences. These factors are helping the Asia Pacific region to emerge as a hotbed for AI-based genomics in the coming years.
Competitive Landscape
The report provides both, qualitative and quantitative research of artificial intelligence (AI) in genomics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of key players operating in the artificial intelligence (AI) in genomics market are Amazon Web Services, Inc., BenevolentAI Ltd., DEEP GENOMICS, Engine Biosciences Pte. Ltd., Fabric Genomics, Inc., FDNA INC., Freenome Holdings, Inc., IBM Corporation, Lifebit, Microsoft, MolecularMatch, Inc., NVIDIA Corporation, Verge Genomics and other market participants.
Artificial Intelligence (AI) In Genomics Market
By Offering
- Solutions
- Services
By Technology
- Machine Learning
- Computer Vision
- Others
By Type
- Plant Genomics
- Animal Genomics
- Others
By Function
- Genome Sequencing
- Gene Editing
- Predictive Testing of Genes
- Others
By Organization Size
- Small and Medium Enterprises
- Large Enterprises
By End-Use
- Structural Genomics
- Functional Genomics
By End-Users
- Pharmaceutical Companies
- Research Institutions and Life Sciences
- Healthcare Providers
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015
- 2029
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021
– 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research
Questionnaire
3.1.2. Global Percentage
Breakdown
3.1.3. Primary Interviews:
Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size
Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation
Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Artificial Intelligence
(AI) in Genomics Market
6. Market Synopsis: Artificial Intelligence (AI) in Genomics
Market
7. Artificial Intelligence (AI) in Genomics
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Artificial
Intelligence (AI) in Genomics Market
7.4. Market Determinants
Radar Chart
7.5. Macro-Economic and
Micro-Economic Indicators: Artificial Intelligence (AI) in Genomics Market
7.6. Porter’s Five Force
Analysis
7.7. COVID-19 Impact on
Global Artificial Intelligence (AI) in Genomics Market
8.
Global Artificial Intelligence
(AI) in Genomics Market Analysis and Forecasts, 2021 – 2029
8.1.
Overview
8.1.1.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn)
8.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1.
Solutions
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and
Penetration, 2015 - 2020
8.2.1.3.
Market Forecast, 2021 - 2029
8.2.1.4.
Compound Annual Growth Rate
(CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
North America
8.2.1.5.1.1.
Market Estimation, 2015 - 2020
8.2.1.5.1.2.
Market Forecast, 2021 - 2029
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market Estimation, 2015 - 2020
8.2.1.5.2.2.
Market Forecast, 2021 - 2029
8.2.1.5.3.
Asia Pacific
8.2.1.5.3.1.
Market Estimation, 2015 - 2020
8.2.1.5.3.2.
Market Forecast, 2021 - 2029
8.2.1.5.4.
Middle East and Africa
8.2.1.5.4.1.
Market Estimation, 2015 - 2020
8.2.1.5.4.2.
Market Forecast, 2021 - 2029
8.2.1.5.5.
Latin America
8.2.1.5.5.1.
Market Estimation, 2015 - 2020
8.2.1.5.5.2.
Market Forecast, 2021 - 2029
8.2.2.
Services
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and
Penetration, 2015 - 2020
8.2.2.3.
Market Forecast, 2021 - 2029
8.2.2.4.
Compound Annual Growth Rate
(CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 - 2020
8.2.2.5.1.2.
Market Forecast, 2021 - 2029
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 - 2020
8.2.2.5.2.2.
Market Forecast, 2021 - 2029
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 - 2020
8.2.2.5.3.2.
Market Forecast, 2021 - 2029
8.2.2.5.4.
Middle East and Africa
8.2.2.5.4.1.
Market Estimation, 2015 - 2020
8.2.2.5.4.2.
Market Forecast, 2021 - 2029
8.2.2.5.5.
Latin America
8.2.2.5.5.1.
Market Estimation, 2015 - 2020
8.2.2.5.5.2.
Market Forecast, 2021 - 2029
8.3.
Key Segment for Channeling Investments
8.3.1.
By Offering
9.
Global Artificial Intelligence
(AI) in Genomics Market Analysis and Forecasts, 2021 – 2029
9.1.
Overview
9.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
9.2.1.
Machine Learning
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and
Penetration, 2015 - 2020
9.2.1.3.
Market Forecast, 2021 - 2029
9.2.1.4.
Compound Annual Growth Rate
(CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1.
Market Estimation, 2015 - 2020
9.2.1.5.1.2.
Market Forecast, 2021 - 2029
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market Estimation, 2015 - 2020
9.2.1.5.2.2.
Market Forecast, 2021 - 2029
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1.
Market Estimation, 2015 - 2020
9.2.1.5.3.2.
Market Forecast, 2021 - 2029
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1.
Market Estimation, 2015 - 2020
9.2.1.5.4.2.
Market Forecast, 2021 - 2029
9.2.1.5.5.
Latin America
9.2.1.5.5.1.
Market Estimation, 2015 - 2020
9.2.1.5.5.2.
Market Forecast, 2021 - 2029
9.2.2.
Computer Vision
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and
Penetration, 2015 - 2020
9.2.2.3.
Market Forecast, 2021 - 2029
9.2.2.4.
Compound Annual Growth Rate
(CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 - 2020
9.2.2.5.1.2.
Market Forecast, 2021 - 2029
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market Estimation, 2015 - 2020
9.2.2.5.2.2.
Market Forecast, 2021 - 2029
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 - 2020
9.2.2.5.3.2.
Market Forecast, 2021 - 2029
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 - 2020
9.2.2.5.4.2.
Market Forecast, 2021 - 2029
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 - 2020
9.2.2.5.5.2.
Market Forecast, 2021 - 2029
9.2.3.
Others
9.2.3.1.
Definition
9.2.3.2.
Market Estimation and
Penetration, 2015 - 2020
9.2.3.3.
Market Forecast, 2021 - 2029
9.2.3.4.
Compound Annual Growth Rate
(CAGR)
9.2.3.5.
Regional Bifurcation
9.2.3.5.1.
North America
9.2.3.5.1.1.
Market Estimation, 2015 - 2020
9.2.3.5.1.2.
Market Forecast, 2021 - 2029
9.2.3.5.2.
Europe
9.2.3.5.2.1.
Market Estimation, 2015 - 2020
9.2.3.5.2.2.
Market Forecast, 2021 - 2029
9.2.3.5.3.
Asia Pacific
9.2.3.5.3.1.
Market Estimation, 2015 - 2020
9.2.3.5.3.2.
Market Forecast, 2021 - 2029
9.2.3.5.4.
Middle East and Africa
9.2.3.5.4.1.
Market Estimation, 2015 - 2020
9.2.3.5.4.2.
Market Forecast, 2021 - 2029
9.2.3.5.5.
Latin America
9.2.3.5.5.1.
Market Estimation, 2015 - 2020
9.2.3.5.5.2.
Market Forecast, 2021 - 2029
9.3.
Key Segment for Channeling Investments
9.3.1.
By Technology
10. Global Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 – 2029
10.1.
Overview
10.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Type
10.2.1.
Plant Genomics
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1.
Market Estimation, 2015 - 2020
10.2.1.5.1.2.
Market Forecast, 2021 - 2029
10.2.1.5.2.
Europe
10.2.1.5.2.1.
Market Estimation, 2015 - 2020
10.2.1.5.2.2.
Market Forecast, 2021 - 2029
10.2.1.5.3.
Asia Pacific
10.2.1.5.3.1.
Market Estimation, 2015 - 2020
10.2.1.5.3.2.
Market Forecast, 2021 - 2029
10.2.1.5.4.
Middle East and Africa
10.2.1.5.4.1.
Market Estimation, 2015 - 2020
10.2.1.5.4.2.
Market Forecast, 2021 - 2029
10.2.1.5.5.
Latin America
10.2.1.5.5.1.
Market Estimation, 2015 - 2020
10.2.1.5.5.2.
Market Forecast, 2021 - 2029
10.2.2.
Animal Genomics
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1.
North America
10.2.2.5.1.1.
Market Estimation, 2015 - 2020
10.2.2.5.1.2.
Market Forecast, 2021 - 2029
10.2.2.5.2.
Europe
10.2.2.5.2.1.
Market Estimation, 2015 - 2020
10.2.2.5.2.2.
Market Forecast, 2021 - 2029
10.2.2.5.3.
Asia Pacific
10.2.2.5.3.1.
Market Estimation, 2015 - 2020
10.2.2.5.3.2.
Market Forecast, 2021 - 2029
10.2.2.5.4.
Middle East and Africa
10.2.2.5.4.1.
Market Estimation, 2015 - 2020
10.2.2.5.4.2.
Market Forecast, 2021 - 2029
10.2.2.5.5.
Latin America
10.2.2.5.5.1.
Market Estimation, 2015 - 2020
10.2.2.5.5.2.
Market Forecast, 2021 - 2029
10.2.3.
Others
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1.
North America
10.2.3.5.1.1.
Market Estimation, 2015 - 2020
10.2.3.5.1.2.
Market Forecast, 2021 - 2029
10.2.3.5.2.
Europe
10.2.3.5.2.1.
Market Estimation, 2015 - 2020
10.2.3.5.2.2.
Market Forecast, 2021 - 2029
10.2.3.5.3.
Asia Pacific
10.2.3.5.3.1.
Market Estimation, 2015 - 2020
10.2.3.5.3.2.
Market Forecast, 2021 - 2029
10.2.3.5.4.
Middle East and Africa
10.2.3.5.4.1.
Market Estimation, 2015 - 2020
10.2.3.5.4.2.
Market Forecast, 2021 - 2029
10.2.3.5.5.
Latin America
10.2.3.5.5.1.
Market Estimation, 2015 - 2020
10.2.3.5.5.2.
Market Forecast, 2021 - 2029
10.3.
Key Segment for Channeling Investments
10.3.1.
By Type
11. Global Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 – 2029
11.1.
Overview
11.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Function
11.2.1.
Genome Sequencing
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2020
11.2.1.3. Market Forecast, 2021 - 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1.
North America
11.2.1.5.1.1.
Market Estimation, 2015 - 2020
11.2.1.5.1.2.
Market Forecast, 2021 - 2029
11.2.1.5.2.
Europe
11.2.1.5.2.1.
Market Estimation, 2015 - 2020
11.2.1.5.2.2.
Market Forecast, 2021 - 2029
11.2.1.5.3.
Asia Pacific
11.2.1.5.3.1.
Market Estimation, 2015 - 2020
11.2.1.5.3.2.
Market Forecast, 2021 - 2029
11.2.1.5.4.
Middle East and Africa
11.2.1.5.4.1.
Market Estimation, 2015 - 2020
11.2.1.5.4.2.
Market Forecast, 2021 - 2029
11.2.1.5.5.
Latin America
11.2.1.5.5.1.
Market Estimation, 2015 - 2020
11.2.1.5.5.2.
Market Forecast, 2021 - 2029
11.2.2.
Gene Editing
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2020
11.2.2.3. Market Forecast, 2021 - 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1.
North America
11.2.2.5.1.1.
Market Estimation, 2015 - 2020
11.2.2.5.1.2.
Market Forecast, 2021 - 2029
11.2.2.5.2.
Europe
11.2.2.5.2.1.
Market Estimation, 2015 - 2020
11.2.2.5.2.2.
Market Forecast, 2021 - 2029
11.2.2.5.3.
Asia Pacific
11.2.2.5.3.1.
Market Estimation, 2015 - 2020
11.2.2.5.3.2.
Market Forecast, 2021 - 2029
11.2.2.5.4.
Middle East and Africa
11.2.2.5.4.1.
Market Estimation, 2015 - 2020
11.2.2.5.4.2.
Market Forecast, 2021 - 2029
11.2.2.5.5.
Latin America
11.2.2.5.5.1.
Market Estimation, 2015 - 2020
11.2.2.5.5.2.
Market Forecast, 2021 - 2029
11.2.3.
Predictive Testing of Genes
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2020
11.2.3.3. Market Forecast, 2021 - 2029
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1.
Market Estimation, 2015 - 2020
11.2.3.5.1.2.
Market Forecast, 2021 - 2029
11.2.3.5.2.
Europe
11.2.3.5.2.1.
Market Estimation, 2015 - 2020
11.2.3.5.2.2.
Market Forecast, 2021 - 2029
11.2.3.5.3.
Asia Pacific
11.2.3.5.3.1.
Market Estimation, 2015 - 2020
11.2.3.5.3.2.
Market Forecast, 2021 - 2029
11.2.3.5.4.
Middle East and Africa
11.2.3.5.4.1.
Market Estimation, 2015 - 2020
11.2.3.5.4.2.
Market Forecast, 2021 - 2029
11.2.3.5.5.
Latin America
11.2.3.5.5.1.
Market Estimation, 2015 - 2020
11.2.3.5.5.2.
Market Forecast, 2021 - 2029
11.2.4.
Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2020
11.2.4.3. Market Forecast, 2021 - 2029
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1.
North America
11.2.4.5.1.1.
Market Estimation, 2015 - 2020
11.2.4.5.1.2.
Market Forecast, 2021 - 2029
11.2.4.5.2.
Europe
11.2.4.5.2.1.
Market Estimation, 2015 - 2020
11.2.4.5.2.2.
Market Forecast, 2021 - 2029
11.2.4.5.3.
Asia Pacific
11.2.4.5.3.1.
Market Estimation, 2015 - 2020
11.2.4.5.3.2.
Market Forecast, 2021 - 2029
11.2.4.5.4.
Middle East and Africa
11.2.4.5.4.1.
Market Estimation, 2015 - 2020
11.2.4.5.4.2.
Market Forecast, 2021 - 2029
11.2.4.5.5.
Latin America
11.2.4.5.5.1.
Market Estimation, 2015 - 2020
11.2.4.5.5.2.
Market Forecast, 2021 - 2029
11.3.
Key Segment for Channeling Investments
11.3.1.
By
Function
12. Global Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 – 2029
12.1.
Overview
12.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Organization Size
12.2.1.
Small and Medium Enterprises
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2020
12.2.1.3. Market Forecast, 2021 - 2029
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1.
North America
12.2.1.5.1.1.
Market Estimation, 2015 - 2020
12.2.1.5.1.2.
Market Forecast, 2021 - 2029
12.2.1.5.2.
Europe
12.2.1.5.2.1.
Market Estimation, 2015 - 2020
12.2.1.5.2.2.
Market Forecast, 2021 - 2029
12.2.1.5.3.
Asia Pacific
12.2.1.5.3.1.
Market Estimation, 2015 - 2020
12.2.1.5.3.2.
Market Forecast, 2021 - 2029
12.2.1.5.4.
Middle East and Africa
12.2.1.5.4.1.
Market Estimation, 2015 - 2020
12.2.1.5.4.2.
Market Forecast, 2021 - 2029
12.2.1.5.5.
Latin America
12.2.1.5.5.1.
Market Estimation, 2015 - 2020
12.2.1.5.5.2.
Market Forecast, 2021 - 2029
12.2.2.
Large Enterprises
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2020
12.2.2.3. Market Forecast, 2021 - 2029
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1.
North America
12.2.2.5.1.1.
Market Estimation, 2015 - 2020
12.2.2.5.1.2.
Market Forecast, 2021 - 2029
12.2.2.5.2.
Europe
12.2.2.5.2.1.
Market Estimation, 2015 - 2020
12.2.2.5.2.2.
Market Forecast, 2021 - 2029
12.2.2.5.3.
Asia Pacific
12.2.2.5.3.1.
Market Estimation, 2015 - 2020
12.2.2.5.3.2.
Market Forecast, 2021 - 2029
12.2.2.5.4.
Middle East and Africa
12.2.2.5.4.1.
Market Estimation, 2015 - 2020
12.2.2.5.4.2.
Market Forecast, 2021 - 2029
12.2.2.5.5.
Latin America
12.2.2.5.5.1.
Market Estimation, 2015 - 2020
12.2.2.5.5.2.
Market Forecast, 2021 - 2029
12.3.
Key Segment for Channeling Investments
12.3.1.
By Organization Size
13. Global Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 – 2029
13.1.
Overview
13.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
13.2.1.
Structural Genomics
13.2.1.1. Definition
13.2.1.2. Market Estimation and Penetration, 2015 - 2020
13.2.1.3. Market Forecast, 2021 - 2029
13.2.1.4. Compound Annual Growth Rate (CAGR)
13.2.1.5. Regional Bifurcation
13.2.1.5.1.
North America
13.2.1.5.1.1.
Market Estimation, 2015 - 2020
13.2.1.5.1.2.
Market Forecast, 2021 - 2029
13.2.1.5.2.
Europe
13.2.1.5.2.1.
Market Estimation, 2015 - 2020
13.2.1.5.2.2.
Market Forecast, 2021 - 2029
13.2.1.5.3.
Asia Pacific
13.2.1.5.3.1.
Market Estimation, 2015 - 2020
13.2.1.5.3.2.
Market Forecast, 2021 - 2029
13.2.1.5.4.
Middle East and Africa
13.2.1.5.4.1.
Market Estimation, 2015 - 2020
13.2.1.5.4.2.
Market Forecast, 2021 - 2029
13.2.1.5.5.
Latin America
13.2.1.5.5.1.
Market Estimation, 2015 - 2020
13.2.1.5.5.2.
Market Forecast, 2021 - 2029
13.2.2.
Functional Genomics
13.2.2.1. Definition
13.2.2.2. Market Estimation and Penetration, 2015 - 2020
13.2.2.3. Market Forecast, 2021 - 2029
13.2.2.4. Compound Annual Growth Rate (CAGR)
13.2.2.5. Regional Bifurcation
13.2.2.5.1.
North America
13.2.2.5.1.1.
Market Estimation, 2015 - 2020
13.2.2.5.1.2.
Market Forecast, 2021 - 2029
13.2.2.5.2.
Europe
13.2.2.5.2.1.
Market Estimation, 2015 - 2020
13.2.2.5.2.2.
Market Forecast, 2021 - 2029
13.2.2.5.3.
Asia Pacific
13.2.2.5.3.1.
Market Estimation, 2015 - 2020
13.2.2.5.3.2.
Market Forecast, 2021 - 2029
13.2.2.5.4.
Middle East and Africa
13.2.2.5.4.1.
Market Estimation, 2015 - 2020
13.2.2.5.4.2.
Market Forecast, 2021 - 2029
13.2.2.5.5.
Latin America
13.2.2.5.5.1.
Market Estimation, 2015 - 2020
13.2.2.5.5.2.
Market Forecast, 2021 - 2029
13.3.
Key Segment for Channeling Investments
13.3.1.
By End-Use
14. Global Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 – 2029
14.1.
Overview
14.2.
Global Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By End-Users
14.2.1.
Pharmaceutical Companies
14.2.1.1. Definition
14.2.1.2. Market Estimation and Penetration, 2015 - 2020
14.2.1.3. Market Forecast, 2021 - 2029
14.2.1.4. Compound Annual Growth Rate (CAGR)
14.2.1.5. Regional Bifurcation
14.2.1.5.1.
North America
14.2.1.5.1.1.
Market Estimation, 2015 - 2020
14.2.1.5.1.2.
Market Forecast, 2021 - 2029
14.2.1.5.2.
Europe
14.2.1.5.2.1.
Market Estimation, 2015 - 2020
14.2.1.5.2.2.
Market Forecast, 2021 - 2029
14.2.1.5.3.
Asia Pacific
14.2.1.5.3.1.
Market Estimation, 2015 - 2020
14.2.1.5.3.2.
Market Forecast, 2021 - 2029
14.2.1.5.4.
Middle East and Africa
14.2.1.5.4.1.
Market Estimation, 2015 - 2020
14.2.1.5.4.2.
Market Forecast, 2021 - 2029
14.2.1.5.5.
Latin America
14.2.1.5.5.1.
Market Estimation, 2015 - 2020
14.2.1.5.5.2.
Market Forecast, 2021 - 2029
14.2.2.
Research Institutions and Life Sciences
14.2.2.1. Definition
14.2.2.2. Market Estimation and Penetration, 2015 - 2020
14.2.2.3. Market Forecast, 2021 - 2029
14.2.2.4. Compound Annual Growth Rate (CAGR)
14.2.2.5. Regional Bifurcation
14.2.2.5.1.
North America
14.2.2.5.1.1.
Market Estimation, 2015 - 2020
14.2.2.5.1.2.
Market Forecast, 2021 - 2029
14.2.2.5.2.
Europe
14.2.2.5.2.1.
Market Estimation, 2015 - 2020
14.2.2.5.2.2.
Market Forecast, 2021 - 2029
14.2.2.5.3.
Asia Pacific
14.2.2.5.3.1.
Market Estimation, 2015 - 2020
14.2.2.5.3.2.
Market Forecast, 2021 - 2029
14.2.2.5.4.
Middle East and Africa
14.2.2.5.4.1.
Market Estimation, 2015 - 2020
14.2.2.5.4.2.
Market Forecast, 2021 - 2029
14.2.2.5.5.
Latin America
14.2.2.5.5.1.
Market Estimation, 2015 - 2020
14.2.2.5.5.2.
Market Forecast, 2021 - 2029
14.2.3.
Healthcare Providers
14.2.3.1. Definition
14.2.3.2. Market Estimation and Penetration, 2015 - 2020
14.2.3.3. Market Forecast, 2021 - 2029
14.2.3.4. Compound Annual Growth Rate (CAGR)
14.2.3.5. Regional Bifurcation
14.2.3.5.1.
North America
14.2.3.5.1.1.
Market Estimation, 2015 - 2020
14.2.3.5.1.2.
Market Forecast, 2021 - 2029
14.2.3.5.2.
Europe
14.2.3.5.2.1.
Market Estimation, 2015 - 2020
14.2.3.5.2.2.
Market Forecast, 2021 - 2029
14.2.3.5.3.
Asia Pacific
14.2.3.5.3.1.
Market Estimation, 2015 - 2020
14.2.3.5.3.2.
Market Forecast, 2021 - 2029
14.2.3.5.4.
Middle East and Africa
14.2.3.5.4.1.
Market Estimation, 2015 - 2020
14.2.3.5.4.2.
Market Forecast, 2021 - 2029
14.2.3.5.5.
Latin America
14.2.3.5.5.1.
Market Estimation, 2015 - 2020
14.2.3.5.5.2.
Market Forecast, 2021 - 2029
14.2.4.
Others
14.2.4.1. Definition
14.2.4.2. Market Estimation and Penetration, 2015 - 2020
14.2.4.3. Market Forecast, 2021 - 2029
14.2.4.4. Compound Annual Growth Rate (CAGR)
14.2.4.5. Regional Bifurcation
14.2.4.5.1.
North America
14.2.4.5.1.1.
Market Estimation, 2015 - 2020
14.2.4.5.1.2.
Market Forecast, 2021 - 2029
14.2.4.5.2.
Europe
14.2.4.5.2.1.
Market Estimation, 2015 - 2020
14.2.4.5.2.2.
Market Forecast, 2021 - 2029
14.2.4.5.3.
Asia Pacific
14.2.4.5.3.1.
Market Estimation, 2015 - 2020
14.2.4.5.3.2.
Market Forecast, 2021 - 2029
14.2.4.5.4.
Middle East and Africa
14.2.4.5.4.1.
Market Estimation, 2015 - 2020
14.2.4.5.4.2.
Market Forecast, 2021 - 2029
14.2.4.5.5.
Latin America
14.2.4.5.5.1.
Market Estimation, 2015 - 2020
14.2.4.5.5.2.
Market Forecast, 2021 - 2029
14.3.
Key Segment for Channeling Investments
14.3.1.
By End-Users
15. North America Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 - 2029
15.1.
Overview
15.1.1.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn)
15.2.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1.
Solutions
15.2.2.
Services
15.3.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
15.3.1.
Machine Learning
15.3.2.
Computer Vision
15.3.3.
Others
15.4.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Type
15.4.1.
Plant Genomics
15.4.2.
Animal Genomics
15.4.3.
Others
15.5.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Function
15.5.1.
Genome Sequencing
15.5.2.
Gene Editing
15.5.3.
Predictive Testing of Genes
15.5.4.
Others
15.6.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Organization Size
15.6.1.
Small and Medium Enterprises
15.6.2.
Large Enterprises
15.7.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
15.7.1.
Structural Genomics
15.7.2.
Functional Genomics
15.8.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Users
15.8.1.
Pharmaceutical Companies
15.8.2.
Research Institutions and Life Sciences
15.8.3.
Healthcare Providers
15.8.4.
Others
15.9.
North America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Country
15.9.1.
U.S
15.9.1.1. U.S Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
15.9.1.1.1.
Solutions
15.9.1.1.2.
Services
15.9.1.2. U.S Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
15.9.1.2.1.
Machine Learning
15.9.1.2.2.
Computer Vision
15.9.1.2.3.
Others
15.9.1.3. U.S Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
15.9.1.3.1.
Plant Genomics
15.9.1.3.2.
Animal Genomics
15.9.1.3.3.
Others
15.9.1.4. U.S Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
15.9.1.4.1.
Genome Sequencing
15.9.1.4.2.
Gene Editing
15.9.1.4.3.
Predictive Testing of Genes
15.9.1.4.4.
Others
15.9.1.5. U.S Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
15.9.1.5.1.
Small and Medium Enterprises
15.9.1.5.2.
Large Enterprises
15.9.1.6. U.S Artificial Intelligence (AI) in Genomics Market Revenue (US$
Mn) and Forecasts, By End-Use
15.9.1.6.1.
Structural Genomics
15.9.1.6.2.
Functional Genomics
15.9.1.7. U.S Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
15.9.1.7.1.
Pharmaceutical Companies
15.9.1.7.2.
Research Institutions and Life Sciences
15.9.1.7.3.
Healthcare Providers
15.9.1.7.4.
Others
15.9.2.
Canada
15.9.2.1. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
15.9.2.1.1.
Solutions
15.9.2.1.2.
Services
15.9.2.2. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
15.9.2.2.1.
Machine Learning
15.9.2.2.2.
Computer Vision
15.9.2.2.3.
Others
15.9.2.3. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
15.9.2.3.1.
Plant Genomics
15.9.2.3.2.
Animal Genomics
15.9.2.3.3.
Others
15.9.2.4. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
15.9.2.4.1.
Genome Sequencing
15.9.2.4.2.
Gene Editing
15.9.2.4.3.
Predictive Testing of Genes
15.9.2.4.4.
Others
15.9.2.5. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
15.9.2.5.1.
Small and Medium Enterprises
15.9.2.5.2.
Large Enterprises
15.9.2.6. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
15.9.2.6.1.
Structural Genomics
15.9.2.6.2.
Functional Genomics
15.9.2.7. Canada Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
15.9.2.7.1.
Pharmaceutical Companies
15.9.2.7.2.
Research Institutions and Life Sciences
15.9.2.7.3.
Healthcare Providers
15.9.2.7.4.
Others
15.9.3.
Mexico
15.9.3.1. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
15.9.3.1.1.
Solutions
15.9.3.1.2.
Services
15.9.3.2. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
15.9.3.2.1.
Machine Learning
15.9.3.2.2.
Computer Vision
15.9.3.2.3.
Others
15.9.3.3. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
15.9.3.3.1.
Plant Genomics
15.9.3.3.2.
Animal Genomics
15.9.3.3.3.
Others
15.9.3.4. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
15.9.3.4.1.
Genome Sequencing
15.9.3.4.2.
Gene Editing
15.9.3.4.3.
Predictive Testing of Genes
15.9.3.4.4.
Others
15.9.3.5. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
15.9.3.5.1.
Small and Medium Enterprises
15.9.3.5.2.
Large Enterprises
15.9.3.6. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
15.9.3.6.1.
Structural Genomics
15.9.3.6.2.
Functional Genomics
15.9.3.7. Mexico Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
15.9.3.7.1.
Pharmaceutical Companies
15.9.3.7.2.
Research Institutions and Life Sciences
15.9.3.7.3.
Healthcare Providers
15.9.3.7.4.
Others
15.9.4.
Rest of North America
15.9.4.1. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Offering
15.9.4.1.1.
Solutions
15.9.4.1.2.
Services
15.9.4.2. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Technology
15.9.4.2.1.
Machine Learning
15.9.4.2.2.
Computer Vision
15.9.4.2.3.
Others
15.9.4.3. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Type
15.9.4.3.1.
Plant Genomics
15.9.4.3.2.
Animal Genomics
15.9.4.3.3.
Others
15.9.4.4. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By
Function
15.9.4.4.1.
Genome Sequencing
15.9.4.4.2.
Gene Editing
15.9.4.4.3.
Predictive Testing of Genes
15.9.4.4.4.
Others
15.9.4.5. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Organization Size
15.9.4.5.1.
Small and Medium Enterprises
15.9.4.5.2.
Large Enterprises
15.9.4.6. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Use
15.9.4.6.1.
Structural Genomics
15.9.4.6.2.
Functional Genomics
15.9.4.7. Rest of North America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Users
15.9.4.7.1.
Pharmaceutical Companies
15.9.4.7.2.
Research Institutions and Life Sciences
15.9.4.7.3.
Healthcare Providers
15.9.4.7.4.
Others
15.10.
Key Segment for Channeling Investments
15.10.1.
By Country
15.10.2.
By Offering
15.10.3.
By Technology
15.10.4.
By Type
15.10.5.
By
Function
15.10.6.
By Organization Size
15.10.7.
By End-Use
15.10.8.
By End-Users
16. Europe Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 - 2029
16.1.
Overview
16.1.1.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn)
16.2.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Offering
16.2.1.
Solutions
16.2.2.
Services
16.3.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
16.3.1.
Machine Learning
16.3.2.
Computer Vision
16.3.3.
Others
16.4.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Type
16.4.1.
Plant Genomics
16.4.2.
Animal Genomics
16.4.3.
Others
16.5.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Function
16.5.1.
Genome Sequencing
16.5.2.
Gene Editing
16.5.3.
Predictive Testing of Genes
16.5.4.
Others
16.6.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Organization Size
16.6.1.
Small and Medium Enterprises
16.6.2.
Large Enterprises
16.7.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
16.7.1.
Structural Genomics
16.7.2.
Functional Genomics
16.8.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By End-Users
16.8.1.
Pharmaceutical Companies
16.8.2.
Research Institutions and Life Sciences
16.8.3.
Healthcare Providers
16.8.4.
Others
16.9.
Europe Artificial Intelligence (AI) in
Genomics Market Revenue (US$ Mn) and Forecasts, By Country
16.9.1.
France
16.9.1.1. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
16.9.1.1.1.
Solutions
16.9.1.1.2.
Services
16.9.1.2. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
16.9.1.2.1.
Machine Learning
16.9.1.2.2.
Computer Vision
16.9.1.2.3.
Others
16.9.1.3. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
16.9.1.3.1.
Plant Genomics
16.9.1.3.2.
Animal Genomics
16.9.1.3.3.
Others
16.9.1.4. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
16.9.1.4.1.
Genome Sequencing
16.9.1.4.2.
Gene Editing
16.9.1.4.3.
Predictive Testing of Genes
16.9.1.4.4.
Others
16.9.1.5. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
16.9.1.5.1.
Small and Medium Enterprises
16.9.1.5.2.
Large Enterprises
16.9.1.6. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
16.9.1.6.1.
Structural Genomics
16.9.1.6.2.
Functional Genomics
16.9.1.7. France Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
16.9.1.7.1.
Pharmaceutical Companies
16.9.1.7.2.
Research Institutions and Life Sciences
16.9.1.7.3.
Healthcare Providers
16.9.1.7.4.
Others
16.9.2.
The UK
16.9.2.1. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
16.9.2.1.1.
Solutions
16.9.2.1.2.
Services
16.9.2.2. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
16.9.2.2.1.
Machine Learning
16.9.2.2.2.
Computer Vision
16.9.2.2.3.
Others
16.9.2.3. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
16.9.2.3.1.
Plant Genomics
16.9.2.3.2.
Animal Genomics
16.9.2.3.3.
Others
16.9.2.4. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
16.9.2.4.1.
Genome Sequencing
16.9.2.4.2.
Gene Editing
16.9.2.4.3.
Predictive Testing of Genes
16.9.2.4.4.
Others
16.9.2.5. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
16.9.2.5.1.
Small and Medium Enterprises
16.9.2.5.2.
Large Enterprises
16.9.2.6. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
16.9.2.6.1.
Structural Genomics
16.9.2.6.2.
Functional Genomics
16.9.2.7. The UK Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
16.9.2.7.1.
Pharmaceutical Companies
16.9.2.7.2.
Research Institutions and Life Sciences
16.9.2.7.3.
Healthcare Providers
16.9.2.7.4.
Others
16.9.3.
Spain
16.9.3.1. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
16.9.3.1.1.
Solutions
16.9.3.1.2.
Services
16.9.3.2. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
16.9.3.2.1.
Machine Learning
16.9.3.2.2.
Computer Vision
16.9.3.2.3.
Others
16.9.3.3. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
16.9.3.3.1.
Plant Genomics
16.9.3.3.2.
Animal Genomics
16.9.3.3.3.
Others
16.9.3.4. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
16.9.3.4.1.
Genome Sequencing
16.9.3.4.2.
Gene Editing
16.9.3.4.3.
Predictive Testing of Genes
16.9.3.4.4.
Others
16.9.3.5. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
16.9.3.5.1.
Small and Medium Enterprises
16.9.3.5.2.
Large Enterprises
16.9.3.6. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
16.9.3.6.1.
Structural Genomics
16.9.3.6.2.
Functional Genomics
16.9.3.7. Spain Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
16.9.3.7.1.
Pharmaceutical Companies
16.9.3.7.2.
Research Institutions and Life Sciences
16.9.3.7.3.
Healthcare Providers
16.9.3.7.4.
Others
16.9.4.
Germany
16.9.4.1. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
16.9.4.1.1.
Solutions
16.9.4.1.2.
Services
16.9.4.2. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
16.9.4.2.1.
Machine Learning
16.9.4.2.2.
Computer Vision
16.9.4.2.3.
Others
16.9.4.3. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
16.9.4.3.1.
Plant Genomics
16.9.4.3.2.
Animal Genomics
16.9.4.3.3.
Others
16.9.4.4. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
16.9.4.4.1.
Genome Sequencing
16.9.4.4.2.
Gene Editing
16.9.4.4.3.
Predictive Testing of Genes
16.9.4.4.4.
Others
16.9.4.5. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
16.9.4.5.1.
Small and Medium Enterprises
16.9.4.5.2.
Large Enterprises
16.9.4.6. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
16.9.4.6.1.
Structural Genomics
16.9.4.6.2.
Functional Genomics
16.9.4.7. Germany Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
16.9.4.7.1.
Pharmaceutical Companies
16.9.4.7.2.
Research Institutions and Life Sciences
16.9.4.7.3.
Healthcare Providers
16.9.4.7.4.
Others
16.9.5.
Italy
16.9.5.1. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
16.9.5.1.1.
Solutions
16.9.5.1.2.
Services
16.9.5.2. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
16.9.5.2.1.
Machine Learning
16.9.5.2.2.
Computer Vision
16.9.5.2.3.
Others
16.9.5.3. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
16.9.5.3.1.
Plant Genomics
16.9.5.3.2.
Animal Genomics
16.9.5.3.3.
Others
16.9.5.4. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
16.9.5.4.1.
Genome Sequencing
16.9.5.4.2.
Gene Editing
16.9.5.4.3.
Predictive Testing of Genes
16.9.5.4.4.
Others
16.9.5.5. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
16.9.5.5.1.
Small and Medium Enterprises
16.9.5.5.2.
Large Enterprises
16.9.5.6. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
16.9.5.6.1.
Structural Genomics
16.9.5.6.2.
Functional Genomics
16.9.5.7. Italy Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
16.9.5.7.1.
Pharmaceutical Companies
16.9.5.7.2.
Research Institutions and Life Sciences
16.9.5.7.3.
Healthcare Providers
16.9.5.7.4.
Others
16.9.6.
Nordic Countries
16.9.6.1. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Offering
16.9.6.1.1.
Solutions
16.9.6.1.2.
Services
16.9.6.2. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Technology
16.9.6.2.1.
Machine Learning
16.9.6.2.2.
Computer Vision
16.9.6.2.3.
Others
16.9.6.3. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Type
16.9.6.3.1.
Plant Genomics
16.9.6.3.2.
Animal Genomics
16.9.6.3.3.
Others
16.9.6.4. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By
Function
16.9.6.4.1.
Genome Sequencing
16.9.6.4.2.
Gene Editing
16.9.6.4.3.
Predictive Testing of Genes
16.9.6.4.4.
Others
16.9.6.5. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Organization Size
16.9.6.5.1.
Small and Medium Enterprises
16.9.6.5.2.
Large Enterprises
16.9.6.6. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Use
16.9.6.6.1.
Structural Genomics
16.9.6.6.2.
Functional Genomics
16.9.6.7. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Users
16.9.6.7.1.
Pharmaceutical Companies
16.9.6.7.2.
Research Institutions and Life Sciences
16.9.6.7.3.
Healthcare Providers
16.9.6.7.4.
Others
16.9.6.8. Nordic Countries Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Country
16.9.6.8.1.
Denmark
16.9.6.8.2.
Finland
16.9.6.8.3.
Iceland
16.9.6.8.4.
Sweden
16.9.6.8.5.
Norway
16.9.7.
Benelux Union
16.9.7.1. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
16.9.7.1.1.
Solutions
16.9.7.1.2.
Services
16.9.7.2. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
16.9.7.2.1.
Machine Learning
16.9.7.2.2.
Computer Vision
16.9.7.2.3.
Others
16.9.7.3. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
16.9.7.3.1.
Plant Genomics
16.9.7.3.2.
Animal Genomics
16.9.7.3.3.
Others
16.9.7.4. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
16.9.7.4.1.
Genome Sequencing
16.9.7.4.2.
Gene Editing
16.9.7.4.3.
Predictive Testing of Genes
16.9.7.4.4.
Others
16.9.7.5. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
16.9.7.5.1.
Small and Medium Enterprises
16.9.7.5.2.
Large Enterprises
16.9.7.6. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
16.9.7.6.1.
Structural Genomics
16.9.7.6.2.
Functional Genomics
16.9.7.7. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
16.9.7.7.1.
Pharmaceutical Companies
16.9.7.7.2.
Research Institutions and Life Sciences
16.9.7.7.3.
Healthcare Providers
16.9.7.7.4.
Others
16.9.7.8. Benelux Union Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Country
16.9.7.8.1.
Belgium
16.9.7.8.2.
The Netherlands
16.9.7.8.3.
Luxembourg
16.9.8.
Rest of Europe
16.9.8.1. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
16.9.8.1.1.
Solutions
16.9.8.1.2.
Services
16.9.8.2. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
16.9.8.2.1.
Machine Learning
16.9.8.2.2.
Computer Vision
16.9.8.2.3.
Others
16.9.8.3. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
16.9.8.3.1.
Plant Genomics
16.9.8.3.2.
Animal Genomics
16.9.8.3.3.
Others
16.9.8.4. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
16.9.8.4.1.
Genome Sequencing
16.9.8.4.2.
Gene Editing
16.9.8.4.3.
Predictive Testing of Genes
16.9.8.4.4.
Others
16.9.8.5. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
16.9.8.5.1.
Small and Medium Enterprises
16.9.8.5.2.
Large Enterprises
16.9.8.6. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
16.9.8.6.1.
Structural Genomics
16.9.8.6.2.
Functional Genomics
16.9.8.7. Rest of Europe Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
16.9.8.7.1.
Pharmaceutical Companies
16.9.8.7.2.
Research Institutions and Life Sciences
16.9.8.7.3.
Healthcare Providers
16.9.8.7.4.
Others
16.10.
Key Segment for Channeling Investments
16.10.1.
By Country
16.10.2.
By Offering
16.10.3.
By Technology
16.10.4.
By Type
16.10.5.
By
Function
16.10.6.
By Organization Size
16.10.7.
By End-Use
16.10.8.
By End-Users
17. Asia Pacific Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 - 2029
17.1.
Overview
17.1.1.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn)
17.2.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Offering
17.2.1.
Solutions
17.2.2.
Services
17.3.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
17.3.1.
Machine Learning
17.3.2.
Computer Vision
17.3.3.
Others
17.4.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Type
17.4.1.
Plant Genomics
17.4.2.
Animal Genomics
17.4.3.
Others
17.5.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Function
17.5.1.
Genome Sequencing
17.5.2.
Gene Editing
17.5.3.
Predictive Testing of Genes
17.5.4.
Others
17.6.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Organization Size
17.6.1.
Small and Medium Enterprises
17.6.2.
Large Enterprises
17.7.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
17.7.1.
Structural Genomics
17.7.2.
Functional Genomics
17.8.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Users
17.8.1.
Pharmaceutical Companies
17.8.2.
Research Institutions and Life Sciences
17.8.3.
Healthcare Providers
17.8.4.
Others
17.9.
Asia Pacific Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Country
17.9.1.
China
17.9.1.1. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
17.9.1.1.1.
Solutions
17.9.1.1.2.
Services
17.9.1.2. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
17.9.1.2.1.
Machine Learning
17.9.1.2.2.
Computer Vision
17.9.1.2.3.
Others
17.9.1.3. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
17.9.1.3.1.
Plant Genomics
17.9.1.3.2.
Animal Genomics
17.9.1.3.3.
Others
17.9.1.4. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
17.9.1.4.1.
Genome Sequencing
17.9.1.4.2.
Gene Editing
17.9.1.4.3.
Predictive Testing of Genes
17.9.1.4.4.
Others
17.9.1.5. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
17.9.1.5.1.
Small and Medium Enterprises
17.9.1.5.2.
Large Enterprises
17.9.1.6. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
17.9.1.6.1.
Structural Genomics
17.9.1.6.2.
Functional Genomics
17.9.1.7. China Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
17.9.1.7.1.
Pharmaceutical Companies
17.9.1.7.2.
Research Institutions and Life Sciences
17.9.1.7.3.
Healthcare Providers
17.9.1.7.4.
Others
17.9.2.
Japan
17.9.2.1. Japan Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
17.9.2.1.1.
Solutions
17.9.2.1.2.
Services
17.9.2.2. Japan Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
17.9.2.2.1.
Machine Learning
17.9.2.2.2.
Computer Vision
17.9.2.2.3.
Others
17.9.2.3. Japan Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
17.9.2.3.1.
Plant Genomics
17.9.2.3.2.
Animal Genomics
17.9.2.3.3.
Others
17.9.2.4. Japan Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
17.9.2.4.1.
Genome Sequencing
17.9.2.4.2.
Gene Editing
17.9.2.4.3.
Predictive Testing of Genes
17.9.2.4.4.
Others
17.9.2.5. Japan Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
17.9.2.5.1.
Small and Medium Enterprises
17.9.2.5.2.
Large Enterprises
17.9.2.6. Japan Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
17.9.2.6.1.
Structural Genomics
17.9.2.6.2.
Functional Genomics
17.9.2.7. Japan Artificial Intelligence (AI) in Genomics Market Revenue (US$
Mn) and Forecasts, By End-Users
17.9.2.7.1.
Pharmaceutical Companies
17.9.2.7.2.
Research Institutions and Life Sciences
17.9.2.7.3.
Healthcare Providers
17.9.2.7.4.
Others
17.9.3.
India
17.9.3.1. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
17.9.3.1.1.
Solutions
17.9.3.1.2.
Services
17.9.3.2. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
17.9.3.2.1.
Machine Learning
17.9.3.2.2.
Computer Vision
17.9.3.2.3.
Others
17.9.3.3. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
17.9.3.3.1.
Plant Genomics
17.9.3.3.2.
Animal Genomics
17.9.3.3.3.
Others
17.9.3.4. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
17.9.3.4.1.
Genome Sequencing
17.9.3.4.2.
Gene Editing
17.9.3.4.3.
Predictive Testing of Genes
17.9.3.4.4.
Others
17.9.3.5. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
17.9.3.5.1.
Small and Medium Enterprises
17.9.3.5.2.
Large Enterprises
17.9.3.6. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
17.9.3.6.1.
Structural Genomics
17.9.3.6.2.
Functional Genomics
17.9.3.7. India Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
17.9.3.7.1.
Pharmaceutical Companies
17.9.3.7.2.
Research Institutions and Life Sciences
17.9.3.7.3.
Healthcare Providers
17.9.3.7.4.
Others
17.9.4.
New Zealand
17.9.4.1. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
17.9.4.1.1.
Solutions
17.9.4.1.2.
Services
17.9.4.2. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
17.9.4.2.1.
Machine Learning
17.9.4.2.2.
Computer Vision
17.9.4.2.3.
Others
17.9.4.3. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
17.9.4.3.1.
Plant Genomics
17.9.4.3.2.
Animal Genomics
17.9.4.3.3.
Others
17.9.4.4. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
17.9.4.4.1.
Genome Sequencing
17.9.4.4.2.
Gene Editing
17.9.4.4.3.
Predictive Testing of Genes
17.9.4.4.4.
Others
17.9.4.5. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
17.9.4.5.1.
Small and Medium Enterprises
17.9.4.5.2.
Large Enterprises
17.9.4.6. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
17.9.4.6.1.
Structural Genomics
17.9.4.6.2.
Functional Genomics
17.9.4.7. New Zealand Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
17.9.4.7.1.
Pharmaceutical Companies
17.9.4.7.2.
Research Institutions and Life Sciences
17.9.4.7.3.
Healthcare Providers
17.9.4.7.4.
Others
17.9.5.
Australia
17.9.5.1. Australia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
17.9.5.1.1.
Solutions
17.9.5.1.2.
Services
17.9.5.2. Australia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
17.9.5.2.1.
Machine Learning
17.9.5.2.2.
Computer Vision
17.9.5.2.3.
Others
17.9.5.3. Australia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
17.9.5.3.1.
Plant Genomics
17.9.5.3.2.
Animal Genomics
17.9.5.3.3.
Others
17.9.5.4. Australia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
17.9.5.4.1.
Genome Sequencing
17.9.5.4.2.
Gene Editing
17.9.5.4.3.
Predictive Testing of Genes
17.9.5.4.4.
Others
17.9.5.5. Australia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
17.9.5.5.1.
Small and Medium Enterprises
17.9.5.5.2.
Large Enterprises
17.9.5.6. Australia Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
17.9.5.6.1.
Structural Genomics
17.9.5.6.2.
Functional Genomics
17.9.5.7. Australia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
17.9.5.7.1.
Pharmaceutical Companies
17.9.5.7.2.
Research Institutions and Life Sciences
17.9.5.7.3.
Healthcare Providers
17.9.5.7.4.
Others
17.9.6.
South Korea
17.9.6.1. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
17.9.6.1.1.
Solutions
17.9.6.1.2.
Services
17.9.6.2. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
17.9.6.2.1.
Machine Learning
17.9.6.2.2.
Computer Vision
17.9.6.2.3.
Others
17.9.6.3. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
17.9.6.3.1.
Plant Genomics
17.9.6.3.2.
Animal Genomics
17.9.6.3.3.
Others
17.9.6.4. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
17.9.6.4.1.
Genome Sequencing
17.9.6.4.2.
Gene Editing
17.9.6.4.3.
Predictive Testing of Genes
17.9.6.4.4.
Others
17.9.6.5. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
17.9.6.5.1.
Small and Medium Enterprises
17.9.6.5.2.
Large Enterprises
17.9.6.6. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
17.9.6.6.1.
Structural Genomics
17.9.6.6.2.
Functional Genomics
17.9.6.7. South Korea Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
17.9.6.7.1.
Pharmaceutical Companies
17.9.6.7.2.
Research Institutions and Life Sciences
17.9.6.7.3.
Healthcare Providers
17.9.6.7.4.
Others
17.9.7.
Southeast Asia
17.9.7.1. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
17.9.7.1.1.
Solutions
17.9.7.1.2.
Services
17.9.7.2. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
17.9.7.2.1.
Machine Learning
17.9.7.2.2.
Computer Vision
17.9.7.2.3.
Others
17.9.7.3. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
17.9.7.3.1.
Plant Genomics
17.9.7.3.2.
Animal Genomics
17.9.7.3.3.
Others
17.9.7.4. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
17.9.7.4.1.
Genome Sequencing
17.9.7.4.2.
Gene Editing
17.9.7.4.3.
Predictive Testing of Genes
17.9.7.4.4.
Others
17.9.7.5. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
17.9.7.5.1.
Small and Medium Enterprises
17.9.7.5.2.
Large Enterprises
17.9.7.6. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
17.9.7.6.1.
Structural Genomics
17.9.7.6.2.
Functional Genomics
17.9.7.7. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
17.9.7.7.1.
Pharmaceutical Companies
17.9.7.7.2.
Research Institutions and Life Sciences
17.9.7.7.3.
Healthcare Providers
17.9.7.7.4.
Others
17.9.7.8. Southeast Asia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Country
17.9.7.8.1.
Indonesia
17.9.7.8.2.
Thailand
17.9.7.8.3.
Malaysia
17.9.7.8.4.
Singapore
17.9.7.8.5.
Rest of Southeast Asia
17.9.8.
Rest of Asia Pacific
17.9.8.1. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Offering
17.9.8.1.1.
Solutions
17.9.8.1.2.
Services
17.9.8.2. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Technology
17.9.8.2.1.
Machine Learning
17.9.8.2.2.
Computer Vision
17.9.8.2.3.
Others
17.9.8.3. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Type
17.9.8.3.1.
Plant Genomics
17.9.8.3.2.
Animal Genomics
17.9.8.3.3.
Others
17.9.8.4. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By
Function
17.9.8.4.1.
Genome Sequencing
17.9.8.4.2.
Gene Editing
17.9.8.4.3.
Predictive Testing of Genes
17.9.8.4.4.
Others
17.9.8.5. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Organization Size
17.9.8.5.1.
Small and Medium Enterprises
17.9.8.5.2.
Large Enterprises
17.9.8.6. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Use
17.9.8.6.1.
Structural Genomics
17.9.8.6.2.
Functional Genomics
17.9.8.7. Rest of Asia Pacific Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Users
17.9.8.7.1.
Pharmaceutical Companies
17.9.8.7.2.
Research Institutions and Life Sciences
17.9.8.7.3.
Healthcare Providers
17.9.8.7.4.
Others
17.10.
Key Segment for Channeling Investments
17.10.1.
By Country
17.10.2.
By Offering
17.10.3.
By Technology
17.10.4.
By Type
17.10.5.
By
Function
17.10.6.
By Organization Size
17.10.7.
By End-Use
17.10.8.
By End-Users
18. Middle East and Africa Artificial Intelligence (AI) in
Genomics Market Analysis and Forecasts, 2021 - 2029
18.1.
Overview
18.1.1.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn)
18.2.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By
Offering
18.2.1.
Solutions
18.2.2.
Services
18.3.
Middle East and Africa Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
18.3.1.
Machine Learning
18.3.2.
Computer Vision
18.3.3.
Others
18.4.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Type
18.4.1.
Plant Genomics
18.4.2.
Animal Genomics
18.4.3.
Others
18.5.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Function
18.5.1.
Genome Sequencing
18.5.2.
Gene Editing
18.5.3.
Predictive Testing of Genes
18.5.4.
Others
18.6.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By
Organization Size
18.6.1.
Small and Medium Enterprises
18.6.2.
Large Enterprises
18.7.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
18.7.1.
Structural Genomics
18.7.2.
Functional Genomics
18.8.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By
End-Users
18.8.1.
Pharmaceutical Companies
18.8.2.
Research Institutions and Life Sciences
18.8.3.
Healthcare Providers
18.8.4.
Others
18.9.
Middle East and Africa Artificial
Intelligence (AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Country
18.9.1.
Saudi Arabia
18.9.1.1. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
18.9.1.1.1.
Solutions
18.9.1.1.2.
Services
18.9.1.2. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
18.9.1.2.1.
Machine Learning
18.9.1.2.2.
Computer Vision
18.9.1.2.3.
Others
18.9.1.3. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
18.9.1.3.1.
Plant Genomics
18.9.1.3.2.
Animal Genomics
18.9.1.3.3.
Others
18.9.1.4. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
18.9.1.4.1.
Genome Sequencing
18.9.1.4.2.
Gene Editing
18.9.1.4.3.
Predictive Testing of Genes
18.9.1.4.4.
Others
18.9.1.5. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
18.9.1.5.1.
Small and Medium Enterprises
18.9.1.5.2.
Large Enterprises
18.9.1.6. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
18.9.1.6.1.
Structural Genomics
18.9.1.6.2.
Functional Genomics
18.9.1.7. Saudi Arabia Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
18.9.1.7.1.
Pharmaceutical Companies
18.9.1.7.2.
Research Institutions and Life Sciences
18.9.1.7.3.
Healthcare Providers
18.9.1.7.4.
Others
18.9.2.
UAE
18.9.2.1. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
18.9.2.1.1.
Solutions
18.9.2.1.2.
Services
18.9.2.2. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
18.9.2.2.1.
Machine Learning
18.9.2.2.2.
Computer Vision
18.9.2.2.3.
Others
18.9.2.3. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
18.9.2.3.1.
Plant Genomics
18.9.2.3.2.
Animal Genomics
18.9.2.3.3.
Others
18.9.2.4. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
18.9.2.4.1.
Genome Sequencing
18.9.2.4.2.
Gene Editing
18.9.2.4.3.
Predictive Testing of Genes
18.9.2.4.4.
Others
18.9.2.5. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
18.9.2.5.1.
Small and Medium Enterprises
18.9.2.5.2.
Large Enterprises
18.9.2.6. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
18.9.2.6.1.
Structural Genomics
18.9.2.6.2.
Functional Genomics
18.9.2.7. UAE Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
18.9.2.7.1.
Pharmaceutical Companies
18.9.2.7.2.
Research Institutions and Life Sciences
18.9.2.7.3.
Healthcare Providers
18.9.2.7.4.
Others
18.9.3.
Egypt
18.9.3.1. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
18.9.3.1.1.
Solutions
18.9.3.1.2.
Services
18.9.3.2. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
18.9.3.2.1.
Machine Learning
18.9.3.2.2.
Computer Vision
18.9.3.2.3.
Others
18.9.3.3. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
18.9.3.3.1.
Plant Genomics
18.9.3.3.2.
Animal Genomics
18.9.3.3.3.
Others
18.9.3.4. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
18.9.3.4.1.
Genome Sequencing
18.9.3.4.2.
Gene Editing
18.9.3.4.3.
Predictive Testing of Genes
18.9.3.4.4.
Others
18.9.3.5. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
18.9.3.5.1.
Small and Medium Enterprises
18.9.3.5.2.
Large Enterprises
18.9.3.6. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
18.9.3.6.1.
Structural Genomics
18.9.3.6.2.
Functional Genomics
18.9.3.7. Egypt Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
18.9.3.7.1.
Pharmaceutical Companies
18.9.3.7.2.
Research Institutions and Life Sciences
18.9.3.7.3.
Healthcare Providers
18.9.3.7.4.
Others
18.9.4.
Kuwait
18.9.4.1. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
18.9.4.1.1.
Solutions
18.9.4.1.2.
Services
18.9.4.2. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
18.9.4.2.1.
Machine Learning
18.9.4.2.2.
Computer Vision
18.9.4.2.3.
Others
18.9.4.3. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
18.9.4.3.1.
Plant Genomics
18.9.4.3.2.
Animal Genomics
18.9.4.3.3.
Others
18.9.4.4. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
18.9.4.4.1.
Genome Sequencing
18.9.4.4.2.
Gene Editing
18.9.4.4.3.
Predictive Testing of Genes
18.9.4.4.4.
Others
18.9.4.5. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
18.9.4.5.1.
Small and Medium Enterprises
18.9.4.5.2.
Large Enterprises
18.9.4.6. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
18.9.4.6.1.
Structural Genomics
18.9.4.6.2.
Functional Genomics
18.9.4.7. Kuwait Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
18.9.4.7.1.
Pharmaceutical Companies
18.9.4.7.2.
Research Institutions and Life Sciences
18.9.4.7.3.
Healthcare Providers
18.9.4.7.4.
Others
18.9.5.
South Africa
18.9.5.1. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
18.9.5.1.1.
Solutions
18.9.5.1.2.
Services
18.9.5.2. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
18.9.5.2.1.
Machine Learning
18.9.5.2.2.
Computer Vision
18.9.5.2.3.
Others
18.9.5.3. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
18.9.5.3.1.
Plant Genomics
18.9.5.3.2.
Animal Genomics
18.9.5.3.3.
Others
18.9.5.4. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
18.9.5.4.1.
Genome Sequencing
18.9.5.4.2.
Gene Editing
18.9.5.4.3.
Predictive Testing of Genes
18.9.5.4.4.
Others
18.9.5.5. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
18.9.5.5.1.
Small and Medium Enterprises
18.9.5.5.2.
Large Enterprises
18.9.5.6. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
18.9.5.6.1.
Structural Genomics
18.9.5.6.2.
Functional Genomics
18.9.5.7. South Africa Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
18.9.5.7.1.
Pharmaceutical Companies
18.9.5.7.2.
Research Institutions and Life Sciences
18.9.5.7.3.
Healthcare Providers
18.9.5.7.4.
Others
18.9.6.
Rest of Middle East & Africa
18.9.6.1. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By Offering
18.9.6.1.1.
Solutions
18.9.6.1.2.
Services
18.9.6.2. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
18.9.6.2.1.
Machine Learning
18.9.6.2.2.
Computer Vision
18.9.6.2.3.
Others
18.9.6.3. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By Type
18.9.6.3.1.
Plant Genomics
18.9.6.3.2.
Animal Genomics
18.9.6.3.3.
Others
18.9.6.4. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By Function
18.9.6.4.1.
Genome Sequencing
18.9.6.4.2.
Gene Editing
18.9.6.4.3.
Predictive Testing of Genes
18.9.6.4.4.
Others
18.9.6.5. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By Organization Size
18.9.6.5.1.
Small and Medium Enterprises
18.9.6.5.2.
Large Enterprises
18.9.6.6. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
18.9.6.6.1.
Structural Genomics
18.9.6.6.2.
Functional Genomics
18.9.6.7. Rest of Middle East & Africa Artificial Intelligence (AI)
in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Users
18.9.6.7.1.
Pharmaceutical Companies
18.9.6.7.2.
Research Institutions and Life Sciences
18.9.6.7.3.
Healthcare Providers
18.9.6.7.4.
Others
18.10.
Key Segment for Channeling Investments
18.10.1.
By Country
18.10.2.
By Offering
18.10.3.
By Technology
18.10.4.
By Type
18.10.5.
By
Function
18.10.6.
By Organization Size
18.10.7.
By End-Use
18.10.8.
By End-Users
19. Latin America Artificial Intelligence (AI) in Genomics Market
Analysis and Forecasts, 2021 - 2029
19.1.
Overview
19.1.1.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn)
19.2.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Offering
19.2.1.
Solutions
19.2.2.
Services
19.3.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Technology
19.3.1.
Machine Learning
19.3.2.
Computer Vision
19.3.3.
Others
19.4.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Type
19.4.1.
Plant Genomics
19.4.2.
Animal Genomics
19.4.3.
Others
19.5.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Function
19.5.1.
Genome Sequencing
19.5.2.
Gene Editing
19.5.3.
Predictive Testing of Genes
19.5.4.
Others
19.6.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Organization Size
19.6.1.
Small and Medium Enterprises
19.6.2.
Large Enterprises
19.7.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Use
19.7.1.
Structural Genomics
19.7.2.
Functional Genomics
19.8.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By End-Users
19.8.1.
Pharmaceutical Companies
19.8.2.
Research Institutions and Life Sciences
19.8.3.
Healthcare Providers
19.8.4.
Others
19.9.
Latin America Artificial Intelligence
(AI) in Genomics Market Revenue (US$ Mn) and Forecasts, By Country
19.9.1.
Brazil
19.9.1.1. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Offering
19.9.1.1.1.
Solutions
19.9.1.1.2.
Services
19.9.1.2. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Technology
19.9.1.2.1.
Machine Learning
19.9.1.2.2.
Computer Vision
19.9.1.2.3.
Others
19.9.1.3. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Type
19.9.1.3.1.
Plant Genomics
19.9.1.3.2.
Animal Genomics
19.9.1.3.3.
Others
19.9.1.4. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Function
19.9.1.4.1.
Genome Sequencing
19.9.1.4.2.
Gene Editing
19.9.1.4.3.
Predictive Testing of Genes
19.9.1.4.4.
Others
19.9.1.5. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By Organization Size
19.9.1.5.1.
Small and Medium Enterprises
19.9.1.5.2.
Large Enterprises
19.9.1.6. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Use
19.9.1.6.1.
Structural Genomics
19.9.1.6.2.
Functional Genomics
19.9.1.7. Brazil Artificial Intelligence (AI) in Genomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
19.9.1.7.1.
Pharmaceutical Companies
19.9.1.7.2.
Research Institutions and Life Sciences
19.9.1.7.3.
Healthcare Providers
19.9.1.7.4.
Others
19.9.2.
Argentina
19.9.2.1. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Offering
19.9.2.1.1.
Solutions
19.9.2.1.2.
Services
19.9.2.2. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Technology
19.9.2.2.1.
Machine Learning
19.9.2.2.2.
Computer Vision
19.9.2.2.3.
Others
19.9.2.3. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Type
19.9.2.3.1.
Plant Genomics
19.9.2.3.2.
Animal Genomics
19.9.2.3.3.
Others
19.9.2.4. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By
Function
19.9.2.4.1.
Genome Sequencing
19.9.2.4.2.
Gene Editing
19.9.2.4.3.
Predictive Testing of Genes
19.9.2.4.4.
Others
19.9.2.5. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By Organization Size
19.9.2.5.1.
Small and Medium Enterprises
19.9.2.5.2.
Large Enterprises
19.9.2.6. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Use
19.9.2.6.1.
Structural Genomics
19.9.2.6.2.
Functional Genomics
19.9.2.7. Argentina Artificial Intelligence (AI) in Genomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
19.9.2.7.1.
Pharmaceutical Companies
19.9.2.7.2.
Research Institutions and Life Sciences
19.9.2.7.3.
Healthcare Providers
19.9.2.7.4.
Others
19.9.3.
Rest of Latin America
19.9.3.1. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Offering
19.9.3.1.1.
Solutions
19.9.3.1.2.
Services
19.9.3.2. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Technology
19.9.3.2.1.
Machine Learning
19.9.3.2.2.
Computer Vision
19.9.3.2.3.
Others
19.9.3.3. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Type
19.9.3.3.1.
Plant Genomics
19.9.3.3.2.
Animal Genomics
19.9.3.3.3.
Others
19.9.3.4. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By
Function
19.9.3.4.1.
Genome Sequencing
19.9.3.4.2.
Gene Editing
19.9.3.4.3.
Predictive Testing of Genes
19.9.3.4.4.
Others
19.9.3.5. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By Organization Size
19.9.3.5.1.
Small and Medium Enterprises
19.9.3.5.2.
Large Enterprises
19.9.3.6. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Use
19.9.3.6.1.
Structural Genomics
19.9.3.6.2.
Functional Genomics
19.9.3.7. Rest of Latin America Artificial Intelligence (AI) in Genomics
Market Revenue (US$ Mn) and Forecasts, By End-Users
19.9.3.7.1.
Pharmaceutical Companies
19.9.3.7.2.
Research Institutions and Life Sciences
19.9.3.7.3.
Healthcare Providers
19.9.3.7.4.
Others
19.10.
Key Segment for Channeling Investments
19.10.1.
By Country
19.10.2.
By Offering
19.10.3.
By Technology
19.10.4.
By Type
19.10.5.
By
Function
19.10.6.
By Organization Size
19.10.7.
By End-Use
19.10.8.
By End-Users
20. Competitive Benchmarking
20.1.
Brand Benchmarking
20.2.
Market Share Analysis, 2020
20.3.
Global Presence and Growth Strategies
20.3.1.
Mergers and Acquisitions
20.3.2.
Product Launches
20.3.3.
Investments Trends
20.3.4.
R&D Initiatives
21. Player Profiles
21.1.
Amazon Web Services, Inc.
21.1.1.
Company Details
21.1.2.
Company Overview
21.1.3.
Product Offerings
21.1.4.
Key Developments
21.1.5.
Financial Analysis
21.1.6.
SWOT Analysis
21.1.7.
Business Strategies
21.2.
BenevolentAI Ltd
21.2.1.
Company Details
21.2.2.
Company Overview
21.2.3.
Product Offerings
21.2.4.
Key Developments
21.2.5.
Financial Analysis
21.2.6.
SWOT Analysis
21.2.7.
Business Strategies
21.3.
DEEP GENOMICS.
21.3.1.
Company Details
21.3.2.
Company Overview
21.3.3.
Product Offerings
21.3.4.
Key Developments
21.3.5.
Financial Analysis
21.3.6.
SWOT Analysis
21.3.7.
Business Strategies
21.4.
Engine Biosciences Pte. Ltd.
21.4.1.
Company Details
21.4.2.
Company Overview
21.4.3.
Product Offerings
21.4.4.
Key Developments
21.4.5.
Financial Analysis
21.4.6.
SWOT Analysis
21.4.7.
Business Strategies
21.5.
Fabric Genomics, Inc.
21.5.1.
Company Details
21.5.2.
Company Overview
21.5.3.
Product Offerings
21.5.4.
Key Developments
21.5.5.
Financial Analysis
21.5.6.
SWOT Analysis
21.5.7.
Business Strategies
21.6.
FDNA INC.
21.6.1.
Company Details
21.6.2.
Company Overview
21.6.3.
Product Offerings
21.6.4.
Key Developments
21.6.5.
Financial Analysis
21.6.6.
SWOT Analysis
21.6.7.
Business Strategies
21.7.
Freenome Holdings, Inc.
21.7.1.
Company Details
21.7.2.
Company Overview
21.7.3.
Product Offerings
21.7.4.
Key Developments
21.7.5.
Financial Analysis
21.7.6.
SWOT Analysis
21.7.7.
Business Strategies
21.8.
IBM Corporation
21.8.1.
Company Details
21.8.2.
Company Overview
21.8.3.
Product Offerings
21.8.4.
Key Developments
21.8.5.
Financial Analysis
21.8.6.
SWOT Analysis
21.8.7.
Business Strategies
21.9.
Lifebit
21.9.1.
Company Details
21.9.2.
Company Overview
21.9.3.
Product Offerings
21.9.4.
Key Developments
21.9.5.
Financial Analysis
21.9.6.
SWOT Analysis
21.9.7.
Business Strategies
21.10.
Microsoft
21.10.1.
Company Details
21.10.2.
Company Overview
21.10.3.
Product Offerings
21.10.4.
Key Developments
21.10.5.
Financial Analysis
21.10.6.
SWOT Analysis
21.10.7.
Business Strategies
21.11.
MolecularMatch, Inc.
21.11.1.
Company Details
21.11.2.
Company Overview
21.11.3.
Product Offerings
21.11.4.
Key Developments
21.11.5.
Financial Analysis
21.11.6.
SWOT Analysis
21.11.7.
Business Strategies
21.12.
NVIDIA Corporation
21.12.1.
Company Details
21.12.2.
Company Overview
21.12.3.
Product Offerings
21.12.4.
Key Developments
21.12.5.
Financial Analysis
21.12.6.
SWOT Analysis
21.12.7.
Business Strategies
21.13.
Verge Genomics
21.13.1.
Company Details
21.13.2.
Company Overview
21.13.3.
Product Offerings
21.13.4.
Key Developments
21.13.5.
Financial Analysis
21.13.6.
SWOT Analysis
21.13.7.
Business Strategies
21.14.
Other Market Participants
22. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.